IRD Opus Genetics trades modestly higher post Q4 2025 earnings despite wider than expected per share losses What is Granite GRNT dividend policy Trend Strengthens 20260427 Is Rein Therapeutics RNTX stock testing important levels Q4 2025 Profit Disappoints